C-RAD

Board/Management Information • May 21, 2021

Press Release 21 May 2021 08:30:00 CEST

C-RAD strengthens its management team

As of May, C-RAD is pleased to announce the addition of two key members to the executive management.

Annica Jämtén Ericsson takes on the position as Director of global services. Annica has an extensive experience from service business development in various industries, especially the medical technology field, with 14 years in Getinge.

Emelie Gessner Gozzi assumes the position as Global marketing director. Emelie has a broad background in marketing with leading roles in branding, leads generation and digital marketing with previous positions in Camfil Svenska, Byggmax and Clas Ohlson.

Ivan Astralaga has been appointed President C-RAD Americas and will in this position be responsible for C-RAD's business in North-, Central and South America. Ivan has extensive experience in sales and business development from, among other companies in the medical technology field, Accuray and Mevion.

C-RADs executive management team is now comprised by CEO Tim Thurn, COO Håkan Axelsson, Global director of services Annica Jämtén Ericsson, Global marketing director Emelie Gessner Gozzi and CFO Henrik Bergentoft. The extended management team is constituted by regional sales leaders; Dirk Freynhagen for EMEA, Ivan Astralaga for Americas and Kurt Xiadong Wang for China.

'I am welcoming the new members to the management team and look forward to work with the team', says CEO Tim Thurn. 'Service and Marketing plays a key role in our strategy to build the company and to make surface tracking standard of care in advanced radiation therapy. With the new setup the management team is well suited to define and implement C-RAD's strategy."

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

Press Release 21 May 2021 08:30:00 CEST

C-RAD strengthens its management team